Everything You Need to Know About Cannabidiol is Right Here
![]() |
Cannabidiol |
A phytocannabinoid called
cannabidiol (CBD) was first identified in 1940. Along with tetrahydrocannabinol
(THC), it is one of 113 cannabinoids found in cannabis plants and makes up up
to 40% of the plant's extract. Although there is insufficient high-quality
evidence that CBD is effective for these conditions as of 2019, clinical
research on CBD has included studies pertaining to studies pertaining to
anxiety, cognition, movement disorders, and pain. However, CBD is a well-liked
herbal dietary supplement that has been heavily marketed with unverified claims
of specific therapeutic benefits.
Cannabidiol can be ingested orally,
through the mouth, as an aerosol spray into the cheek, or by inhaling cannabis
smoke or vapour. It can be given in the form of capsules, dried cannabis,
CBD-dominant hemp extract oil, or prescription liquid solution.
Tetrahydrocannabinol (THC) and terpenes are not allowed to be present in CBD
oil.
The global Cannabidiol
Market size was estimated to be valued at US$ 3665.5 Million in 2021, and
is expected to witness a CAGR of 47.3% over the forecast period (2021-2028).
Two cannabinoids that are naturally present in the resin of the marijuana plant are tetrahydrocannabinol (THC) and cannabidiol (CBD), both of which interact with the cannabinoid receptors that are distributed throughout the body. Although THC and CBD have received the most attention in research, there are numerous other cannabinoids present in medical cannabis that have been identified to date, such as cannabinol (CBN), cannabigerol (CBG), cannabidivarin (CBDV), and tetrahydrocannabivarin (THCV).
While both CBD and THC are used
medicinally, their physiological effects and receptor activity are different.
Unless offered in their activated form (such as through synthetic forms of THC
like Dronabinol or Nabilone). Epidiolex, a prescription oil, is the only CBD
product currently recognised by the Food and Drug Administration. It is
authorised to treat two different types of epilepsy. State regulations on the
use of CBD vary, aside from Epidiolex. Although a variety of conditions, such
as Parkinson's disease, schizophrenia, diabetes, multiple sclerosis, and
anxiety are being treated with CBD, there is still little evidence to support
the drug's therapeutic effects.
Comments
Post a Comment